Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 8
2003 10
2004 22
2005 23
2006 25
2007 39
2008 40
2009 37
2010 59
2011 75
2012 79
2013 79
2014 83
2015 94
2016 121
2017 115
2018 176
2019 169
2020 205
2021 225
2022 282
2023 244
2024 100

Text availability

Article attribute

Article type

Publication date

Search Results

2,029 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
Ares-Gómez S, Mallah N, Santiago-Pérez MI, Pardo-Seco J, Pérez-Martínez O, Otero-Barrós MT, Suárez-Gaiche N, Kramer R, Jin J, Platero-Alonso L, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Piñeiro-Sotelo M, Malvar-Pintos A, González-Pérez JM, Rodríguez-Tenreiro-Sánchez C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F; NIRSE-GAL study group. Ares-Gómez S, et al. Among authors: jin j. Lancet Infect Dis. 2024 Apr 30:S1473-3099(24)00215-9. doi: 10.1016/S1473-3099(24)00215-9. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38701823
Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study.
Tang R, Zeng Y, Zhou Y, Liang Q, Kang W, Yang Z, Zheng X, Zang X, Pan H, Jin J, Zhu F. Tang R, et al. Among authors: jin j. Expert Rev Vaccines. 2024 Jan-Dec;23(1):498-509. doi: 10.1080/14760584.2024.2337051. Epub 2024 May 2. Expert Rev Vaccines. 2024. PMID: 38695310 Free article. Clinical Trial.
2,029 results